Staudt, Louis M.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature

Lymphoma Diagnosis and TreatmentBreast Cancer Treatment Studies

Cited by 9,925

Genetics and pathogenesis of diffuse large B-cell lymphoma

Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment

Cited by 2,241

Toward a Shared Vision for Cancer Genomic Data

Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M. (2016) · New England Journal of Medicine

Cancer Genomics and DiagnosticsResearch Data Management Practices

Cited by 1,680

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine

Lymphoma Diagnosis and TreatmentImmune cells in cancer

Cited by 1,262

The chromatin accessibility landscape of primary human cancers

Corces, M. R., Granja, J. M., Shams, S., Louie, B. H., Seoane, J. A., Zhou, W., Silva, T. C., Groeneveld, C., Wong, C. K., Cho, S. W., et al. (2018) · Science

Genomics and Chromatin DynamicsChromatin Remodeling and Cancer

Cited by 1,230

Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell

NF-κB Signaling PathwaysMultiple Myeloma Research and Treatments

Cited by 952

JAKs and STATs in immunity, immunodeficiency, and cancer

O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine

Cytokine Signaling Pathways and InteractionsImmunodeficiency and Autoimmune Disorders

Cited by 927

IRF4 addiction in multiple myeloma

Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature

Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment

Cited by 730

'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns

Hastie, T., Tibshirani, R., Eisen, M. B., Alizadeh, A., Levy, R., Staudt, L., Chan, W. C., Botstein, D., & Brown, P. (2000) · Genome Biology

Gene expression and cancer classificationBioinformatics and Genomic Networks

Cited by 547

Oncogenic Activation of NF- B

Staudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology

NF-κB Signaling PathwaysSignaling Pathways in Disease

Cited by 485

Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation

Tunyaplin, C., Shaffer, A. L., Angelin-Duclos, C. D., Yu, X., Staudt, L. M., & Calame, K. L. (2004) · The Journal of Immunology

T-cell and B-cell ImmunologyGenomics and Chromatin Dynamics

Cited by 376

Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells

Sawai, C. M., Sisirak, V., Ghosh, H. S., Hou, E. Z., Ceribelli, M., Staudt, L. M., & Reizis, B. (2013) · Journal of Experimental Medicine

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 133

TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate

Venturutti, L., Teater, M., Zhai, A., Chadburn, A., Babiker, L., Kim, D., Béguelin, W., Lee, T. C., Kim, Y., Chin, C. R., et al. (2020) · Cell

Lymphoma Diagnosis and TreatmentT-cell and B-cell Immunology

Cited by 127

Janus kinase deregulation in leukemia and lymphoma

Chen, E., Staudt, L. M., & Green, A. R. (2012) · Immunity

Cytokine Signaling Pathways and InteractionsAcute Myeloid Leukemia Research

Cited by 123

Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4

Huang, X., Di Liberto, M., Jayabalan, D., Liang, J., Ely, S., Bretz, J., Shaffer, A. L., Louie, T., Chen, I., Randolph, S., et al. (2012) · Blood

Multiple Myeloma Research and TreatmentsCancer-related Molecular Pathways

Cited by 102

Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice

Park, S. S., Shaffer, A. L., Kim, J. S., duBois, W., Potter, M., Staudt, L. M., & Janz, S. (2005) · Cancer Research

Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment

Cited by 27

A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs

Thornton, A. M., Ogryzko, V. V., Dent, A., Sharf, R., Levi, B. Z., Kanno, Y., Staudt, L. M., Howard, B. H., & Ozato, K. (1996) · The Journal of Immunology

interferon and immune responsesCytokine Signaling Pathways and Interactions

Cited by 25